Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg

Description

In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder – Managing Challenging Behaviours

Dr Sam Mehr

Dr Sam Mehr

Paediatric Allergic Rhinitis & Immunotherapy

Prof Rodney Baber AM

Prof Rodney Baber AM

Premature Ovarian Insufficiency – The New Guidelines

Dr Richard Bradlow

Dr Richard Bradlow

Alcohol Addiction Assessment and Advice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Robert Hungerford

expert

Dr Robert Hungerford

GP Supervisor with a special interest in Heart Failure, ASCVD and Diabetes, Marketown Health; Conjoint lecturer, University of Newcastle

Date published: 7 October 2025